1.800.979.8292

Pathology Laboratory Services

Serving more than 3,000 patients each day, Miraca Life Sciences is a leader in providing an academic-caliber clinical pathology laboratory with diagnostic services in the fields of dermatology, gastroenterology, hematology and urology. Building upon our experience with health IT, we also offer accessible EHR solutions to assist healthcare professionals as they work towards accordance with Meaningful Use initiatives.

We employ a talented team of leading pathologists, histologists, lab technicians, technology consultants, and other medical professionals — all driven to help provide the highest and most up-to-date levels of diagnostic quality, enhanced workflow and practice solutions possible. It’s part of our commitment: not only to scientific excellence, but to you.

Pathology Publications

Our skilled team of field-specific clinical pathologists, consultants and experts work diligently to stay at the forefront of the ever-changing landscape of a pathology laboratory and health IT. As part of this diligence, we work closely with one another to provide the highest quality, academic-based research and information possible.

Equip yourself with powerful information on specific conditions and diseases with Miraca Life Sciences. Learn More
EHRpath™ Discover how Miraca Life Sciences is easing the complexities of Meaningful Use criteria for physicians. Learn More

Recent News


February 21, 2013

Miraca Life Sciences Donates $100,000 to ASGE's IT&T Capital Campaign to Build a New State-of-the-Art GI Training Center

The American Society for Gastrointestinal Endoscopy (ASGE) Foundation has received a donation of $100,000 from Miraca Life Sciences to ASGE's IT&T Capital Campaign, a fundraising project to construct a new facility that will provide cutting-edge technology and training capabilities to significantly optimize current educational opportunities. The donation will be made over five years.

Continue reading


January 15, 2013

Miraca Life Sciences Announces New Testing Protocol for Patients with Gastroesophageal Adenocarcinoma

Irving, Texas, January 15, 2013 – Miraca Life Sciences is excited to announce the initiation of a new testing protocol that will aid in the management of patients with gastroesophageal adenocarcinoma. This protocol is in response to the 2010 "ToGA" (Trastuzumab in Gastric cancer) clinical trial that demonstrated a clear survival benefit for combining …

Continue reading


Featured Subspecialty Expert


Jonathan N. Glickman, MD, PhD - Director of GI Pathology, Boston

Jonathan N. Glickman, MD, PhD

Director of GI Pathology, Boston

more